Correction: Liu et al. Endostatin 33 Peptide Is a Deintegrin α6β1 Agent That Exerts Antitumor Activity by Inhibiting the PI3K-Akt Signaling Pathway in Prostate Cancer. J. Clin. Med. 2023, 12 , 1861.
Yang LiuChang-Lin WangZhong-Qi PangKe GaoLin-Kun ShenWan-Hai XuMing-Hua RenPublished in: Journal of clinical medicine (2024)
In the original publication [...].